---
title: Emerging genetic technologies informing personalized medicine in SDS and other
  inherited bone marrow failure disorders
date: '2024-06-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38905596/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240622182853&v=2.18.0.post9+e462414
source: Blood
description: The ribosomopathy Shwachman-Diamond syndrome (SDS) is a rare autosomal
  recessive inherited bone marrow failure syndrome (IBMFS) caused by mutations in
  the Shwachman-Bodian-Diamond syndrome (SBDS) gene, that is associated with an increased
  risk of myeloid malignancy. Tracking how hematopoietic stem cell (HSC) clonal dynamics
  change over time, assessing whether somatic genetic rescue mechanisms affect these
  dynamics, and mapping out when leukemic driver mutations are acquired is important
  ...
disable_comments: true
---
The ribosomopathy Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive inherited bone marrow failure syndrome (IBMFS) caused by mutations in the Shwachman-Bodian-Diamond syndrome (SBDS) gene, that is associated with an increased risk of myeloid malignancy. Tracking how hematopoietic stem cell (HSC) clonal dynamics change over time, assessing whether somatic genetic rescue mechanisms affect these dynamics, and mapping out when leukemic driver mutations are acquired is important ...